Publication | Closed Access
Astragaloside IV and Cycloastragenol Stimulate the Phosphorylation of Extracellular Signal-Regulated Protein Kinase in Multiple Cell Types
45
Citations
0
References
2011
Year
Telomerase ActivityErk KinaseImmunologyDominant Negative MutantsCell ProliferationCytoskeletonCycloastragenol StimulateCellular PhysiologySignaling PathwayCell InteractionReceptor Tyrosine KinaseAutophagyCellular Regulatory MechanismCell SignalingCell PhysiologyBiochemistryMultiple Cell TypesAstragaloside IvCell BiologyTumor MicroenvironmentProtein PhosphorylationSignal TransductionNatural SciencesCellular BiochemistryMedicine
Two Chinese herb-derived small molecule telomerase activators, astragaloside IV (AG-IV) and cycloastragenol (CAG), have recently been shown to improve the proliferative response of CD8+ T lymphocytes from HIV-infected patients by upregulating telomerase activity. Here, we examined the signaling mechanism of AG-IV and CAG. Telomerase activity in human embryonic kidney HEK293 fibroblasts was increased upon treatment with increasing concentrations of AG-IV or CAG. Both compounds induced the phosphorylation of extracellular signal-regulated protein kinase (ERK) in a time- and dose-dependent manner in HEK293 cells and HEK-neo keratinocytes. AG-IV and CAG also stimulated ERK phosphorylation in other cell lines of lung, brain, mammary, endothelial, and hematopoietic origins. Use of selective inhibitors and dominant negative mutants revealed the involvement of c-Src, MEK (ERK kinase), and epidermal growth factor receptor in CAG-induced ERK phosphorylation. Our data indicate that AG-IV and CAG may exert their cellular effects through the activation of the Src/MEK/ERK pathway.